Nuvectis Pharma, Inc. Common Stock (NVCT) Stock Price
NVCTStock
$25.89+247.45%52W
Market Cap$845.15M
P/E—
PEG Ratio—
Div yield—
Beta-0.24
NVCT Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)165.35%
Price vs S&P 500 (4W)17.38%
VGM Score96.59
NVCT Earnings Surprise History
Q2 25-0.30est. -0.25
Q3 25-0.44est. -0.25
Q4 25-0.31est. -0.31
Q1 26-0.26est. -0.31
Q2 26-0.30est. -0.26
NVCT Analyst Recommendations
May 2026
Jun 2026
Jul 2026
Aug 2026
4.09
4.09
4.09
4.09
Industry Peers — Pharmaceuticals(571)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
NVCTNuvectis Pharma, Inc. Common Stock | — | — | A | $25.89 |
| LLYEli Lilly & Co. | D | B | B | $1233.66 |
| JNJJohnson & Johnson | D | C | B | $273.14 |
| ABBVABBVIE INC. | D | C | B | $265.79 |
| MRKMerck & Co., Inc. | D | C | A | $156.45 |
| NVSNovartis AG | C | C | C | $159.98 |
| AZNAstraZeneca PLC | C | B | C | $169.66 |
| NVONovo-Nordisk A/S | B | C | C | $48.66 |
| ABTAbbott Laboratories | C | C | B | $116.13 |
| PFEPfizer Inc. | C | D | C | $28.57 |
| VRTXVertex Pharmaceuticals Inc | D | C | B | $552.85 |
About Nuvectis Pharma, Inc. Common Stock
Nuvectis Pharma is a biopharmaceutical company focused on precision oncology. It develops novel, targeted small-molecule therapeutics for cancer patients with specific genetic profiles. The company's pipeline includes NXP800 and NXP900.